LP-08 80mg
PhaseII LP-08 IC/BPS
Phase 2 small_molecule completed
Quick answer
LP-08 80mg for Interstitial Cystitis is a Phase 2 program (small_molecule) at LIPELLA PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIPELLA PHARMACEUTICALS INC.
- Indication
- Interstitial Cystitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed